RSS Feed Print
Participants Sought for Alzheimer's Clinical Trial
Posted: Tuesday, July 17, 2012 1:49 AM
Joined: 12/6/2011
Posts: 3326

From Alzheimer's Daily News:

(Source: Business Wire) - The James J. Peters Veterans Hospital in Bronx, New York, is actively recruiting participants for a phase IIb clinical trial testing NIC5-15, a disease modifying candidate for Alzheimer's disease.

Humanetics Corporation has developed the use of NIC5-15 in collaboration with Mount Sinai School of Medicine's Alzheimer's Disease Research Center (ADRC), a comprehensive clinical program and research facility. The US Patent and Trademark Office issued a patent for the use of NIC5-15 in June. Humanetics has exclusively licensed the patent through MSSM's Office of Technology and Business Development.


NIC5-15 has been shown in preclinical studies and animal models to be effective in preventing the formation of beta-amyloid plaques, which are believed to be a leading cause of Alzheimer's disease. Multiple clinical studies in non-Alzheimer's populations have demonstrated the safety and phamacokinetics of NIC5-15.


For more information on participation in the Phase IIb clinical trial, please contact Sabrina Lopez at 718-584-9000 x5179.


Go to full story: